{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:04:03Z","timestamp":1774263843909,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011840","name":"Shantou University Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012282","name":"National Human Genetic Resources Sharing Service Platform, Beijing Innovation Center","doi-asserted-by":"publisher","award":["YCZYPT[2017]01-2"],"award-info":[{"award-number":["YCZYPT[2017]01-2"]}],"id":[{"id":"10.13039\/501100012282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007421","name":"Li Ka Shing Foundation Cross-Disciplinary Research","doi-asserted-by":"publisher","award":["2020LKSFG19B"],"award-info":[{"award-number":["2020LKSFG19B"]}],"id":[{"id":"10.13039\/100007421","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong University Innovation Team Project","award":["2019KCXTD003"],"award-info":[{"award-number":["2019KCXTD003"]}]},{"name":"Guangdong High-level University Development Program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.numecd.2020.10.019","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T20:11:55Z","timestamp":1604347915000},"page":"602-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The loss-of-function mutation of CETP affects HDLc levels but not ApoA1 in patients with acute myocardial infarction"],"prefix":"10.1016","volume":"31","author":[{"given":"Weiping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuerui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.numecd.2020.10.019_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2015.09.031","article-title":"HDL cholesterol and stroke risk: the Multi-Ethnic Study of Atherosclerosis","volume":"243","author":"Reina","year":"2015","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.numecd.2020.10.019_bib2","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"Jama"},{"issue":"19","key":"10.1016\/j.numecd.2020.10.019_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM198911093211907","article-title":"High-density lipoprotein-the clinical implications of recent studies","volume":"321","author":"Gordon","year":"1989","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.numecd.2020.10.019_bib4","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.numecd.2020.10.019_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/eurheartj\/ehs019","article-title":"Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial","volume":"33","author":"Luscher","year":"2012","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.numecd.2020.10.019_bib6","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.numecd.2020.10.019_bib7","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.numecd.2020.10.019_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","article-title":"Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL","volume":"84","author":"Zannis","year":"2006","journal-title":"J Mol Med (Berl, Germany)"},{"issue":"12","key":"10.1016\/j.numecd.2020.10.019_bib9","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/ATVBAHA.112.255711","article-title":"Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations","volume":"32","author":"Holleboom","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.numecd.2020.10.019_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.numecd.2020.10.019_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.numecd.2020.10.019_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2020.10.019_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2013.09.009","article-title":"Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis","volume":"231","author":"Sung","year":"2013","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.numecd.2020.10.019_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.numecd.2020.10.019_bib15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Group","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.10.019_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","article-title":"Mendelian randomization: new applications in the coming age of hypothesis-free causality","volume":"16","author":"Evans","year":"2015","journal-title":"Annu Rev Genom Hum Genet"},{"issue":"22","key":"10.1016\/j.numecd.2020.10.019_bib17","first-page":"1857","article-title":"Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study","volume":"95","author":"Teo","year":"2009","journal-title":"Heart (Br Card Soc)"},{"issue":"5","key":"10.1016\/j.numecd.2020.10.019_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1067\/mhj.2001.114974","article-title":"INTER-HEART: a global study of risk factors for acute myocardial infarction","volume":"141","author":"Ounpuu","year":"2001","journal-title":"Am Heart J"},{"issue":"9438","key":"10.1016\/j.numecd.2020.10.019_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.numecd.2020.10.019_bib20","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/oby.2009.138","article-title":"Association of two CETP polymorphisms with HDL levels in the Chinese obese population","volume":"17","author":"Ruan","year":"2009","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"7","key":"10.1016\/j.numecd.2020.10.019_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2016.11.056","article-title":"Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease","volume":"69","author":"Webb","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.numecd.2020.10.019_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2017.11467","article-title":"Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk","volume":"318","author":"Ference","year":"2017","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.numecd.2020.10.019_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamacardio.2017.4177","article-title":"Association of CETP gene variants with risk for vascular and nonvascular diseases among Chinese adults","volume":"3","author":"Millwood","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"6278","key":"10.1016\/j.numecd.2020.10.019_bib24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science (New York, NY)"},{"issue":"9841","key":"10.1016\/j.numecd.2020.10.019_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"25","key":"10.1016\/j.numecd.2020.10.019_bib26","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.numecd.2020.10.019_bib27","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.numecd.2020.10.019_bib28","first-page":"553","article-title":"An increased high-density lipoprotein cholesterol\/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality","volume":"101","author":"Sung","year":"2015","journal-title":"Heart (Br Card Soc)"},{"issue":"9634","key":"10.1016\/j.numecd.2020.10.019_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study","volume":"372","author":"McQueen","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.numecd.2020.10.019_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2018.10.072","article-title":"Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week","volume":"73","author":"Armitage","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2020.10.019_bib31","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1172\/JCI116802","article-title":"A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins","volume":"92","author":"Takahashi","year":"1993","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.numecd.2020.10.019_bib32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1203\/01.pdr.0000183782.57705.fc","article-title":"Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children","volume":"58","author":"Thu","year":"2005","journal-title":"Pediatr Res"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320304580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320304580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:14:21Z","timestamp":1760544861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475320304580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0939475320304580"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2020.10.019","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The loss-of-function mutation of CETP affects HDLc levels but not ApoA1 in patients with acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2020.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}